Beschreibung
InhaltsangabePreface: Onder Ergonul and Chris A. Whitehouse Section I: Introduction and Historical Perspectives 1. Introduction: Onder Ergonul and Chris A. Whitehouse 2. A Historical Perspective of Infectious Diseases with Reference to Crimean-Congo Hemorrhagic Fever: Berna Arda and Ahmet Aciduman 3. Personal Reflections: Jack Woodall Section II: Etiologic agent 4. Molecular Biology of the Crimean-Congo Hemorrhagic Fever Virus: Ramon Flick 5. Molecular Epidemiology, Genomics, and Phylogeny of the Crimean-Congo Hemorrhagic Fever Virus: Roger Hewson Section III: Epidemiology and ecology 6. CrimeanCongo Hemorrhagic Fever in Turkey: Zati Vatansever, Ramazan Uzun, Agustin EstradaPena, Onder Ergonul 7. CrimeanCongo Hemorrhagic Fever in the Balkans: Tatjana AvsicZupanc 8. CrimeanCongo Hemorrhagic Fever in Iran: Sadegh Chinikar 9. CrimeanCongo Hemorrhagic Fever in Russia and the Former Soviet Union: A.M. Butenko and G.G. Karganova 10. CrimeanCongo Hemorrhagic Fever CCHF in the Xinjiang Uygur Autonomous Region of Western China: Masayuki Saijo 11. CrimeanCongo Hemorrhagic Fever in South Africa: Felicity J. Burt and Robert Swanepoel 12. Role of Ticks in the Transmission of Crimean-Congo Hemorrhagic Fever Virus: Mike Turell 13. Infection among Animals: Aysegul Nalca and Chris A. Whitehouse 14. Ecology of Disease and the Role of Climate Change: Sarah Randolph and David J. Rogers 15. Predicative Models of Infection: Ben Cooper Section IV: Clinical Features and Pathogenesis 16. Clinical and Pathologic Features of Crimean-Congo Hemorrhagic Fever: Onder Ergonul 17. Pathogenesis of Crimean-Congo Hemorrhagic Fever and Correlation with other Viral Hemorragic Fevers: Mike Bray 18. Laboratory Diagnosis of Crimean-Congo Hemorrhagic Fever: Herve Zeller 19. Treatment of Crimean-Congo Hemorrhagic Fever 19.1. Current Therapy: Ribavirin Use and Hematological Support: Onder Ergonul 19.2. Old and New Treatment Strategies: Ali Mirazimi 19.3. Antibodies to CCHFV for Prophylaxis And Treatment: Mitko Dimitrov Section V: Prevention and Control 20. Risk Groups and Control of Tick Vectors: Chris A. Whitehouse 21. Estimates and Prevention of Crimean Congo Hemorrhagic Fever Risks for Health Care Workers: Arnaud Tarantola, Onder Ergonul, Pierre Tattevin 22. International Surveillance and Control of Crimean-Congo Hemorrhagic Fever Outbreaks: Pierre Formenty, Glenn Schnepf, Fernando Gonzalez-Martin, and Zhenqiang Bi Section VI: Remaining questions and future research Future Research: Onder Ergonul and Chris A. Whitehouse Frequently Asked Questions Index
Inhalt
InhaltsangabePreface: Onder Ergonul and Chris A. Whitehouse Section I: Introduction and Historical Perspectives 1. Introduction: Onder Ergonul and Chris A. Whitehouse 2. A Historical Perspective of Infectious Diseases with Reference to Crimean-Congo Hemorrhagic Fever: Berna Arda and Ahmet Aciduman 3. Personal Reflections: Jack Woodall Section II: Etiologic agent 4. Molecular Biology of the Crimean-Congo Hemorrhagic Fever Virus: Ramon Flick 5. Molecular Epidemiology, Genomics, and Phylogeny of the Crimean-Congo Hemorrhagic Fever Virus: Roger Hewson Section III: Epidemiology and ecology 6. CrimeanCongo Hemorrhagic Fever in Turkey: Zati Vatansever, Ramazan Uzun, Agustin EstradaPena, Onder Ergonul 7. CrimeanCongo Hemorrhagic Fever in the Balkans: Tatjana AvsicZupanc 8. CrimeanCongo Hemorrhagic Fever in Iran: Sadegh Chinikar 9. CrimeanCongo Hemorrhagic Fever in Russia and the Former Soviet Union: A.M. Butenko and G.G. Karganova 10. CrimeanCongo Hemorrhagic Fever CCHF in the Xinjiang Uygur Autonomous Region of Western China: Masayuki Saijo 11. CrimeanCongo Hemorrhagic Fever in South Africa: Felicity J. Burt and Robert Swanepoel 12. Role of Ticks in the Transmission of Crimean-Congo Hemorrhagic Fever Virus: Mike Turell 13. Infection among Animals: Aysegul Nalca and Chris A. Whitehouse 14. Ecology of Disease and the Role of Climate Change: Sarah Randolph and David J. Rogers 15. Predicative Models of Infection: Ben Cooper Section IV: Clinical Features and Pathogenesis 16. Clinical and Pathologic Features of Crimean-Congo Hemorrhagic Fever: Onder Ergonul 17. Pathogenesis of Crimean-Congo Hemorrhagic Fever and Correlation with other Viral Hemorragic Fevers: Mike Bray 18. Laboratory Diagnosis of Crimean-Congo Hemorrhagic Fever: Herve Zeller 19. Treatment of Crimean-Congo Hemorrhagic Fever 19.1. Current Therapy: Ribavirin Use and Hematological Support: Onder Ergonul 19.2. Old and New Treatment Strategies: Ali Mirazimi 19.3. Antibodies to CCHFV for Prophylaxis And Treatment: Mitko Dimitrov Section V: Prevention and Control 20. Risk Groups and Control of Tick Vectors: Chris A. Whitehouse 21. Estimates and Prevention of Crimean Congo Hemorrhagic Fever Risks for Health Care Workers: Arnaud Tarantola, Onder Ergonul, Pierre Tattevin 22. International Surveillance and Control of Crimean-Congo Hemorrhagic Fever Outbreaks: Pierre Formenty, Glenn Schnepf, Fernando Gonzalez-Martin, and Zhenqiang Bi Section VI: Remaining questions and future research Future Research: Onder Ergonul and Chris A. Whitehouse Frequently Asked Questions Index
